REGISTER for the 27th Annual Meeting in Baltimore, MD or virtually! We look forward to seeing you May 7-11.
ASGCT is involved in collaborative activities to provide expert input into regulatory and commercialization issues surrounding gene and cell therapy. These collaborations are designed to overcome significant challenges and promote certain values, such as quality, safety and standardization. ASGCT members provide expertise as representatives in the following groups on an ongoing basis:
Alliance for Regenerative Medicine Gene and Gene Therapy Technology Section
Foundation for Accreditation of Cellular Therapy (FACT) Professional Relations Committee
National Academies of Sciences, Engineering and Medicine Forum on Regenerative Medicine
Standards Coordinating Body – Gene Therapy Sector and Cell Therapy Sector
Through coalitions, ASGCT advocates for federal research funding and educates policy makers about gene and cell therapy
Learn about ASGCT's most recent legislative actions and join our collaborative efforts.
May 7-11, 2024 | Baltimore, MD
© 2000-2024 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico